+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Selective inhibition of the tumor marker AKR1B10 by antiinflammatory N-phenylanthranilic acids and glycyrrhetic acid



Selective inhibition of the tumor marker AKR1B10 by antiinflammatory N-phenylanthranilic acids and glycyrrhetic acid



Biological and Pharmaceutical Bulletin 33(5): 886-890



A human aldose reductase-like protein, AKR1B10 in the aldo-keto reductase (AKR) superfamily, was recently identified as a tumor marker of several types of cancer. Tolrestat, an aldose reductase inhibitor (ARI), is known to be the most potent inhibitor of the enzyme. In this study, we compared the inhibitory effects of other ARIs including flavonoids on AKR1B10 and aldose reductase to evaluate their specificity. However, ARIs showed lower inhibitory potency for AKR1B10 than for aldose reductase. In the search for potent and selective inhibitors of AKR1B10 from other drugs used clinically, we found that non-steroidal antiinflammatory N-phenylanthranilic acids, diclofenac and glycyrrhetic acid competitively inhibited AKR1B10, showing K(i) values of 0.35-2.9 microM and high selectivity to this enzyme (43-57 fold versus aldose reductase). Molecular docking studies of mefenamic acid and glycyrrhetic acid in the AKR1B10-nicotinamide adenine dinucleotide phosphate (NADP(+)) complex and site-directed mutagenesis of the putative binding residues suggest that the side chain of Val301 and a hydrogen-bonding network among residues Val301, Gln114 and Ser304 are important for determining the inhibitory potency and selectivity of the non-steroidal antiinflammatory drugs. Thus, the potent and selective inhibition may be related to the cancer chemopreventive roles of the drugs, and their structural features may facilitate the design of new anti-cancer agents targeting AKR1B10.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055695414

Download citation: RISBibTeXText

PMID: 20460771

DOI: 10.1248/bpb.33.886


Related references

Potent and selective inhibition of the tumor marker AKR1B10 by bisdemethoxycurcumin: probing the active site of the enzyme with molecular modeling and site-directed mutagenesis. Biochemical and Biophysical Research Communications 389(1): 128-132, 2009

Synthesis and antiinflammatory and antiulcer properties of glycyrrhetic acid derivatives containing fragments of amino acids or their methyl ethers. Pharmaceutical Chemistry Journal 34(5): 250-253, 2000

Statil suppresses cancer cell growth and proliferation by the inhibition of tumor marker AKR1B10. Anti-Cancer Drugs 25(8): 930-937, 2014

Direct determination of serum glycyrrhetic acid by a monoclonal antibody-based inhibition ELISA using ibuprofen for releasing serum albumin-bound glycyrrhetic acid. Journal of Immunoassay 17(4): 343-352, 1996

Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid. Journal of Natural Products 74(5): 1201-1206, 2011

Synthesis, antiinflammatory and antiulcer activity of glycyrrhetic acid derivatives containing fragments of aminoacids or their methyl esters. Khimiko-Farmatsevticheskii Zhurnal 34(5): 28-30, 2000

Quantitative analysis of biologically active derivatives of phenylanthranilic acid and acridine determination of phenylanthranilic acid derivatives by the method of biphasic titration. Farmatsevtychnyi Zhurnal (Kiev) (5): 43-46, 1990

Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10. Proceedings of the National Academy of Sciences of the United States of America 104(52): 20764-9, 2007

Separation and analysis of glycyrrhizin, 18b-glycyrrhetic acid and 18a-glycyrrhetic acid in liquorice roots by means of capillary zone electrophoresis. Journal of chromatography A 15 1081(1): 65-71, 2005

Effect of pH on metabolism of glycyrrhizin, glycyrrhetic acid and glycyrrhetic acid monoglucuronide by collected human intestinal flora. Biological & Pharmaceutical Bulletin 24(10): 1108-1112, 2001

Separation and analysis of glycyrrhizin, 18beta-glycyrrhetic acid and 18alpha-glycyrrhetic acid in liquorice roots by means of capillary zone electrophoresis. Journal of Chromatography. a 1081(1): 65-71, 2005

Differences in the metabolism of glycyrrhizin, glycyrrhetic acid and glycyrrhetic acid monoglucuronide by human intestinal flora. Biological and Pharmaceutical Bulletin 23(12): 1418-1423, 2000

Simultaneous determination of glycyrrhizin, glycyrrhetic acid and glycyrrhetic acid mono-glucuronide in Shakuyaku-kanzo-to incubated with rat feces by semi-micro high-performance liquid chromatography. Biological & Pharmaceutical Bulletin 24(10): 1161-1164, 2001

Selective inhibition of the cyclooxygenase pathway of the arachidonic acid cascade by the nonsteroidal antiinflammatory drug isoxicam. Drug Development Research 5(2): 171-178, 1985

Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids. Journal of Immunology 136(8): 3006-3011, 1986